Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Electrocore Inc (NQ: ECOR )

6.280 +0.170 (+2.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,493
Open 6.000
Bid (Size) 5.510 (2)
Ask (Size) 7.000 (34)
Prev. Close 6.110
Today's Range 5.910 - 6.280
52wk Range 3.829 - 8.080
Shares Outstanding 4,749,221
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ECOR Stock Earnings: electroCore Beats EPS, Beats Revenue for Q1 2024
ECOR stock results show that electroCore beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
+5.19%
+5.19%
1 Month
-9.05%
-9.05%
3 Month
+3.12%
+3.12%
6 Month
+12.75%
+12.75%
1 Year
+53.17%
+53.17%

More News

Read More
Earnings Scheduled For March 13, 2024
Via Benzinga
A Preview Of electroCore's Earnings
Via Benzinga
electroCore Earnings Perspective: Return On Capital Employed
Via Benzinga
iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
DBV Technologies And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
electroCore: Q1 Earnings Insights
Via Benzinga
Electrocore Inc. (NASDAQ: ECOR) Near the Top of Equities by Percentage Gain on 3/24
Via Investor Brand Network
NFL-Funded Study: CBD Or Non-Invasive Vagal Nerve Stimulation - Which Is Better To Alleviate Concussion Symptoms
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study
From electroCore, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
electroCore Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of electroCore's Earnings
Via Benzinga
electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury
From electroCore, Inc.
Via GlobeNewswire
electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank
From electroCore, Inc.
Via GlobeNewswire
electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting
From electroCore, Inc.
Via GlobeNewswire
electroCore to Participate at 35th Annual Roth Conference
From electroCore, Inc.
Via GlobeNewswire
Earnings Scheduled For March 8, 2023
Via Benzinga
electroCore Regains Compliance with Nasdaq Listing Requirements
From electroCore, Inc.
Via GlobeNewswire
electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8
From electroCore, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.